Application Type
National
Application SubType
(10) Registration Number and Date
10202401124V
Status
ACTIVE ( W10)
(180) Expiration Date
(20) Filing Number and Date
SG 10202401124V 2023.12.31
(40) Publication Number and Date
(86) PCT Filing Number and Date
(87) PCT Publication Number and Date
Patent Family
(85) National Entry Date
(30) Priority Details
US
US62/847,854
2018.12.30
US62/935,069
US62/938,218
(51) IPC Classes
    (71/73) Applicant
    (72) Inventor
    (74) Representative
    (54) Title
    (57) Abstract
    (EN)   ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS Abstract The disclosure relates to anti-cancer compounds derived from nuclear steroid receptor binders, to products containing the same, as well as to methods of their use and preparation. No accompanying figure 188  
    (58) Citations
    License Details
    (98) Annuity Details
    YearValidity StartValidity EndPayment
    Document Type Date Action
    Description (with claims) 2024-04-17T00:00:00Z
    Abstract 2024-04-17T00:00:00Z
    Event NameDateLink
    W102019-12-29
    W102023-12-31
    W102023-12-31
    W102023-12-31

    ▲